A further explanation, though mainly conjectural, is worthv of consideration. Before anti-D immunoglobulin was available it was not uncommon to encounter Rh-negative women who formed Rh-antibodies, but the titres remained low and they had only mildly affected infants. Possibly anti-D immunoglobulin can suppress "good" responders but not these low responders. Undoubtedly there is a point of no return, as was seen in the case outlined above: although anti-D was given the mother's second and third child both succumbed to the Rh antibodies.
Introduction
In most cases of chronic heart block the aetiology is unknown. The commonest finding at necropsy is end-stage fibrosis of the bundle of His and its branches.' 2 Complete heart block has occasionally been described in thyroid disorders, including primary myxoedema3 and thyrotoxicosis.4 This study was instituted to assess the frequency of thyroid disease in patients with chronic heart block. In view of the autoimmune aetiology of most cases of primary hypothyroidism, together with the known associations between lymphomatous thyroiditis, pernicious anaemia, vitiligo, Addison's disease, and diabetes mellitus,5 the prevalence of these disorders was also determined. The serum of all patients studied was screened for organspecific and non-organ-specific autoantibodies.
Subjects and Methods
One hundred consecutive patients with chronic heart block admitted to hospital for pacemaker implantation were studied. (Patients with acute heart block-for example, after myocardial infarction-were not included.) Altogether 49 were men and 51 women and their ages ranged from 33 to 96 years (mean 72-4 years) (table I). The duration of their disease, as judged by the time from the onset of symptoms, was 3 months to 23 years (mean 6 years). A detailed personal and family history was taken and the patients were examined for any known cause of heart block and for the presence of vitiligo, thyroid disease, diabetes, or pernicious anaemia. Biochemical screening included haemoglobin, erythrocyte sedimentation rate, urea and electrolytes, Wassermann reaction (W.R.), calcium, phosphate and alkaline phosphatase, plasma proteins, serum thyroxine and Thyopac-3 index, and, when appropriate, serum vitamin B12 level. In 40 patients immunoglobulin levels were determined. Sera were collected and stored at -20°C and tested by us within three months.
Controls.-One hundred healthy people matched for age and sex with the heart-block patients were selected from a larger group tested at the Middlesex Hospital. They consisted of residents in old people's homes and, for the younger age groups, friends of rheumatoid arthritis patients who had accompanied them to hospital.
Serological Methods.-Autoantibodies were detected by a standard sandwich immunofluorescence technique using rabbit antihuman FAB conjugated with fluorescein isothiocyanate. Sera were tested at a 1/10 dilution on human thyroid and stomnach and on rat liver and kidney sections.6 Thyroid microsomal antibodies were titrated by the Fujizoki haemagglutination test, and thyroglobulin antibody was detected by tanned red cell haemagglutination (T.R.C.).
Results
Of the 100 cases of chronic heart block 85 were clinically idiopathic and in 15 a possible cause coexisted, including ischaemic heart disease, calcific aortic valve disease, and Paget's disease. Sixteen patients had diseases associated with organ-specific autoimmunity and three had multiple disorders (table II). All had chronic heart block of unknown Two other patients had multiple autoimmune disorders-a 61-year-old woman with heart block, pernicious anaemia, hypothyroidism, and insulin-dependent diabetes; and a 68-year-old man with vitiligo, heart block, and diabetes mellitus.
The serological results for the whole group are given in table III.
There was no significant difference overall in the prevalence of autoantibodies between the heart-block and control groups. Of the 40 patients whose immunoglobulins were determined 25 were found to have raised IgM levels and 11 raised IgG levels; these increases, however, were not statistically significant.
Discussion
Idiopathic bundle-branch fibrosis is thought to be an end-stage change of damaged Purkinje tissue.8 Current hypotheses are that it is secondary to a myopathic process' or to a fibrocalcific ageing change.9 Round-cell infiltration was noted in eight out of 62 cases described by Len&grel and has been reported by many others since, but these cells were presumed not to be involved in the pathogenesis of heart block. Zoob and Smith'°s uggested that autoimmunity might be involved in heart block, but this hypothesis was not followed up. Myocarditis has also been implicated." Bundle-branch fibrosis is probably not a single disease because similar changes occur in other disordersfor example, familial prolongation of the Q-T interval.'2 Fibrosis selectively replacing the conducting tissue has been produced experimentally as a sequel to a chronic graft rejection reaction in a dog heart homograft."3 It is difficult to select a group of patients to study with idiopathic bundle-branch fibrosis. Harris et al.2 showed that some of these patients have angina without necropsy evidence of coronary stenosis. Either a narrow or the more usually widened QRS complex on the electrocardiogram is compatible with this diagnosis. Chronic heart block has been associated with diabetes,' rheumatoid arthritis,'4 and a previous history of diphtheria. '5 To compare the prevalence of autoimmune disease in this group with that in the normal population precise statistics are required. Many of the published surveys are of hospital patients, and these results may exceed those in old people in the community. The prevalence of pernicious anaemia varies with age, sex, race, and geography. It reaches a peak around the 7th to 8th decades. In Britain, Scott16 found an overall prevalence of 1-27 cases per 1000, with the lowest rates in the south-east (0-6 per 1000), from which area our patients were drawn. A similar survey by Mosbech'7 in Denmark gave a peak prevalence of 3 per 1000 for people aged 60-80 years.
Lloyd and Goldberg'8 found 53 cases of primary hypothyroidism among 3417 geriatric hospital patients-a prevalence of 1 6001. The peak prevalence was in the 6th to 8th decades.
This compares with the prevalence of 400 in our series of patients.
Vitiligo occurs in about 10/ of the population, with over half of the cases arising before the age of 20. In four of the five cases reported here the disorder had become apparent in adolescence or early adulthood. In one of the largest surveys carried out, Grunnet et al. '9 found vitiligo in 1-4400 of Danish hospital patients; 3-70, of those with vitiligo also had pernicious anaemia.
The prevalence of thyroglobulin and thyroid microsomal and gastric parietal cell antibodies is dependent on age and sex. In the population studied by Hooper et al.20 gastric parietal cell antibodies were detected by immunofluorescence in up to 1000 of people aged between 60 and 80 years and thyroid antibodies in up to 12% of cases. About 50% of this age group were positive for rheumatoid factor. The findings in our study of 8% positive for gastric parietal cell antibodies and 700/ positive for thyroid microsomal antibodies are usual for this age group. The Fujizoki test, which is more sensitive than immunofluorescence at a 1/10 dilution, gave a positive result in 150% of cases.
In conclusion, therefore, our results suggest an association between vitiligo, primary hypothyroidism, pernicious anaemia, and idiopathic chronic heart block. Specific antibodies to conducting tissue have recently been detected2' but it is unlikely that humoral immunity alone is the pathogenic factor in idiopathic heart block.
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